Campbell Newman Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-4,862
Closed -$483K 123
2019
Q3
$483K Sell
4,862
-24
-0.5% -$2.28K 0.07% 107
2019
Q2
$452K Sell
4,886
-72
-1% -$6.84K 0.07% 108
2019
Q1
$468K Buy
4,958
+38
+0.8% +$3.32K 0.07% 109
2018
Q4
$315K Buy
4,920
+27
+0.6% +$1.99K 0.05% 118
2018
Q3
$438K Buy
4,893
+135
+3% +$11.9K 0.06% 110
2018
Q2
$378K Sell
4,758
-261
-5% -$21.7K 0.06% 114
2018
Q1
$448K Sell
5,019
-45
-0.9% -$4.32K 0.07% 103
2017
Q4
$528K Sell
5,064
-38
-0.7% -$4.29K 0.09% 90
2017
Q3
$744K Buy
5,102
+63
+1% +$8.58K 0.13% 72
2017
Q2
$654K Sell
5,039
-15
-0.3% -$1.84K 0.12% 75
2017
Q1
$629K Sell
5,054
-56
-1% -$6.7K 0.12% 73
2016
Q4
$591K Sell
5,110
-90
-2% -$10K 0.11% 74
2016
Q3
$544K Sell
5,200
-383
-7% -$41.5K 0.1% 77
2016
Q2
$551K Sell
5,583
-1,166
-17% -$121K 0.1% 82
2016
Q1
$676K Sell
6,749
-27
-0.4% -$2.78K 0.14% 54
2015
Q4
$811K Sell
6,776
-200
-3% -$23.1K 0.18% 56
2015
Q3
$755K Sell
6,976
-12
-0.2% -$1.49K 0.17% 57
2015
Q2
$809K Sell
6,988
-22
-0.3% -$2.52K 0.16% 56
2015
Q1
$808K Sell
7,010
-229
-3% -$27.4K 0.15% 58
2014
Q4
$810K Sell
7,239
-50
-0.7% -$5.27K 0.15% 57
2014
Q3
$691K Sell
7,289
-727
-9% -$65.6K 0.14% 64
2014
Q2
$688K Sell
8,016
-260
-3% -$19.8K 0.14% 66
2014
Q1
$578K Buy
+8,276
New +$655K 0.12% 71

Other funds holding CELG

Campbell Newman Asset Management's CELG Position: Q4 2019 in Review

Campbell Newman Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,862 shares — an estimated $483K sold.

Campbell Newman Asset Management first reported a position in CELG in Q1 2014 and held it in 23 quarters. The position peaked at $811K in Q4 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Campbell Newman Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Campbell Newman Asset Management sold 4,862 Celgene Corp shares in Q4 2019, an estimated $483K.
  • Campbell Newman Asset Management first reported a position in Celgene Corp in Q1 2014 and held it in 23 quarters.
  • Campbell Newman Asset Management's Celgene Corp position peaked at $811K in Q4 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Campbell Newman Asset Management's 13F filing for Q4 2019, filed 22 Jan 2020.